Co-founder and Chairman of the Board, AirXpanders
| Role | Organisation | Sources |
|---|---|---|
| Co-founder and Chairman of the Board | AirXpanders | GBS Ventures (Fri 31 Aug 2018), GBS Ventures (Tue 12 Jun 2018), GBS Ventures (Fri 27 Apr 2018), GBS Ventures (Fri 5 May 2017) |
Stories naming Barry Cheskin. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Medical device maker AirXpanders completed a private placement first announced in August 2018, issuing shares to Vivo Ventures and its chairman Barry Cheskin to raise about US$3.4 million, notifying the ASX accordingly.
Medical device maker AirXpanders appoints US industry veteran Frank Grillo as chief executive, succeeding interim leader Scott Murcray, with co-founder Barry Cheskin welcoming the hire ahead of Grillo fronting July's investor call.
AirXpanders' quarterly update: steady revenue, cost cuts and headcount reductions, Scott Murcray interim CEO while the board searches for a permanent chief, and a planned move to Australian distributors.
US-based medical device maker AirXpanders, listed on the ASX, proposes adding Liz Hammack to its board as co-founder Teddy Shalon departs and fellow director Dennis Condon faces re-election at its May annual meeting.
ASX-listed breast reconstruction device maker AirXpanders secured commitments for a 20 million dollar placement at 76 cents per CDI, and appointed Scott Murcray CFO/COO ahead of its planned US launch.